Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Asset Utilization Ratio: 2020-2025

Historic Asset Utilization Ratio for Kymera Therapeutics (KYMR) over the last 5 years, with Sep 2025 value amounting to -0.00.

  • Kymera Therapeutics' Asset Utilization Ratio fell 100.23% to -0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.00, marking a year-over-year decrease of 100.23%. This contributed to the annual value of 0.00 for FY2024, which is 97.01% down from last year.
  • Latest data reveals that Kymera Therapeutics reported Asset Utilization Ratio of -0.00 as of Q3 2025, which was down 129.56% from 0.00 recorded in Q2 2025.
  • Kymera Therapeutics' 5-year Asset Utilization Ratio high stood at 0.14 for Q2 2021, and its period low was -0.00 during Q3 2025.
  • In the last 3 years, Kymera Therapeutics' Asset Utilization Ratio had a median value of 0.08 in 2023 and averaged 0.06.
  • Per our database at Business Quant, Kymera Therapeutics' Asset Utilization Ratio surged by 84.72% in 2023 and then slumped by 100.23% in 2025.
  • Quarterly analysis of 5 years shows Kymera Therapeutics' Asset Utilization Ratio stood at 0.12 in 2021, then tumbled by 35.36% to 0.08 in 2022, then spiked by 84.72% to 0.14 in 2023, then plummeted by 97.79% to 0.00 in 2024, then plummeted by 100.23% to -0.00 in 2025.
  • Its last three reported values are -0.00 in Q3 2025, 0.00 for Q2 2025, and 0.02 during Q1 2025.